QuidelOrtho Corp (QDEL) Stock Analysis
Verdict: AVOID
High debt ($2.83B) and FCF burn (-$83M) overshadow cheap 0.36x P/S valuation, leaving credit covenant survival as the sole swing factor.
Investment score: 29/100
Analysis as of
Is QuidelOrtho Corp stock worth reviewing? The TradeMates thesis
The model rates QDEL as AVOID with a score of 29/100, driven by $2.83B in debt, negative FCF, and downgraded earnings guidance.
7-factor investment score
- Valuation: 30/100 (weight 20%)
- Financial Health: 15/100 (weight 15%)
- Technical Momentum: 40/100 (weight 15%)
- Earnings Quality: 35/100 (weight 15%)
- Insider Sentiment: 45/100 (weight 10%)
- Analyst Consensus: 20/100 (weight 10%)
- Risk-Adjusted Return: 20/100 (weight 15%)
QuidelOrtho Corp opportunities and risks
What speaks for QDEL
- Deeply discounted revenue valuation relative to medical device peers
What speaks against QDEL
- Severe debt overhang and liquidity strain
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| QDEL | n/a | 0.4x | n/a | 44.6% | -39.2% | -22.1% |
| LNTH | 23.8x | 4.2x | 13.9x | 60.1% | 17.7% | 5.9% |
| HAE | 58.9x | 4.1x | 24.8x | 57.4% | 7.1% | 5.3% |
| MMSI | 36.6x | 3.4x | 15.8x | 49.5% | 9.2% | 3.8% |
| MMED | n/a | 1.6x | 29.1x | 53.8% | -10.2% | -6.2% |
| ICUI | 139.4x | 1.9x | 20.8x | 37.6% | 1.4% | 3.7% |
| Peer median | 36.6x | 3.4x | 20.8x | 53.8% | 7.1% | 3.8% |
Frequently asked questions about QuidelOrtho Corp (QDEL)
Is QDEL stock a good investment?
The TradeMates model rates QuidelOrtho Corp as AVOID with an investment score of 29/100. The model rates QDEL as AVOID with a score of 29/100, driven by $2.83B in debt, negative FCF, and downgraded earnings guidance. This is algorithmic model output, not personal investment advice.
Is QDEL stock a buy?
The TradeMates model verdict for QDEL is AVOID with an investment score of 29/100. Treat this as a model signal to review, not a personal buy recommendation.